Pito Chickering
Stock Analyst at Deutsche Bank
(4.42)
# 1,204
Out of 4,690 analysts
377
Total ratings
60.7%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Pito Chickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $107 → $98 | $100.91 | -2.88% | 18 | Aug 6, 2026 | |
| MDLN Medline | Rated: Hold | $42 → $37 | $35.28 | +4.88% | 4 | Aug 6, 2026 | |
| DVA DaVita | Rated: Buy | $220 → $265 | $180.68 | +46.67% | 22 | Aug 5, 2026 | |
| MD Pediatrix Medical Group | Rated: Hold | $19 → $25 | $26.61 | -6.05% | 20 | Aug 5, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $60 → $70 | $59.13 | +18.38% | 8 | Aug 3, 2026 | |
| BAX Baxter International | Maintained: Hold | $20 → $27 | $26.13 | +3.33% | 16 | Jul 31, 2026 | |
| LH Labcorp Holdings | Rated: Hold | $248 → $306 | $335.11 | -8.69% | 14 | Jul 31, 2026 | |
| OPCH Option Care Health | Downgraded: Hold | $26 → $24 | $23.90 | +0.42% | 18 | Jul 30, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $108 → $60 | $46.84 | +28.10% | 18 | Jul 30, 2026 | |
| HCA HCA Healthcare | Rated: Buy | $441 → $476 | $417.82 | +13.92% | 21 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $32 | $28.55 | +12.08% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $402 → $315 | $330.69 | -4.74% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $16 | $17.15 | -6.71% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $20.10 | -0.50% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9.5 | $5.79 | +64.08% | 18 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $11.51 | +91.14% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $12 | $13.32 | -13.66% | 11 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $94 | $90.21 | n/a | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $136 → $178 | $242.76 | n/a | 14 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.85 | $0.3975 | n/a | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $26 → $18 | $0.015 | n/a | 13 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 → $241 | $321.68 | n/a | 12 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 → $240 | $171.66 | n/a | 16 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $79 → $85 | $91.23 | n/a | 21 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $95 | $120.85 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $266.80 | n/a | 17 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $62 | $29.11 | n/a | 1 | Apr 19, 2021 |
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Hold
Price Target: $107 → $98
Current: $100.91
Upside: -2.88%
Medline
Aug 6, 2026
Rated: Hold
Price Target: $42 → $37
Current: $35.28
Upside: +4.88%
DaVita
Aug 5, 2026
Rated: Buy
Price Target: $220 → $265
Current: $180.68
Upside: +46.67%
Pediatrix Medical Group
Aug 5, 2026
Rated: Hold
Price Target: $19 → $25
Current: $26.61
Upside: -6.05%
BrightSpring Health Services
Aug 3, 2026
Rated: Buy
Price Target: $60 → $70
Current: $59.13
Upside: +18.38%
Baxter International
Jul 31, 2026
Maintained: Hold
Price Target: $20 → $27
Current: $26.13
Upside: +3.33%
Labcorp Holdings
Jul 31, 2026
Rated: Hold
Price Target: $248 → $306
Current: $335.11
Upside: -8.69%
Option Care Health
Jul 30, 2026
Downgraded: Hold
Price Target: $26 → $24
Current: $23.90
Upside: +0.42%
Boston Scientific
Jul 30, 2026
Maintained: Buy
Price Target: $108 → $60
Current: $46.84
Upside: +28.10%
HCA Healthcare
Jul 27, 2026
Rated: Buy
Price Target: $441 → $476
Current: $417.82
Upside: +13.92%
May 1, 2026
Maintained: Buy
Price Target: $26 → $32
Current: $28.55
Upside: +12.08%
May 1, 2026
Maintained: Hold
Price Target: $402 → $315
Current: $330.69
Upside: -4.74%
Apr 30, 2026
Maintained: Hold
Price Target: $18 → $16
Current: $17.15
Upside: -6.71%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $20.10
Upside: -0.50%
Feb 25, 2026
Maintained: Hold
Price Target: $9.5
Current: $5.79
Upside: +64.08%
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $11.51
Upside: +91.14%
Sep 15, 2025
Maintained: Buy
Price Target: $7 → $12
Current: $13.32
Upside: -13.66%
Jul 25, 2025
Maintained: Buy
Price Target: $85 → $94
Current: $90.21
Upside: n/a
Jul 23, 2025
Maintained: Hold
Price Target: $136 → $178
Current: $242.76
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $5 → $2.85
Current: $0.3975
Upside: n/a
Nov 8, 2024
Rated: Hold
Price Target: $26 → $18
Current: $0.015
Upside: n/a
Oct 31, 2024
Maintained: Buy
Price Target: $205 → $241
Current: $321.68
Upside: n/a
Oct 28, 2024
Reiterated: Buy
Price Target: $208 → $240
Current: $171.66
Upside: n/a
Aug 20, 2024
Reiterated: Hold
Price Target: $79 → $85
Current: $91.23
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $83 → $95
Current: $120.85
Upside: n/a
Jul 24, 2024
Rated: Buy
Price Target: $155
Current: $266.80
Upside: n/a
Apr 19, 2021
Maintained: Hold
Price Target: $62
Current: $29.11
Upside: n/a